Targeted Therapies in Oncology: Matching Drugs to Mutations
Learn how targeted therapies match drugs to cancer-driving mutations, advancing precision oncology and improving treatment outcomes.
Liquid Biopsy and Early Cancer Detection: Promise and Limitations
Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring.
Precision Medicine in Oncology Isn’t the Future - It’s Already Late
by: Shraddha HakaniPublished on: 17/05/2026Precision medicine in oncology is no longer a distant vision- it is a critical necessity. As cancer care evolves, biomarker-driven diagnostics, genomic sequencing, digital pathology, and AI-powered insights are transforming how clinicians detect.
Tumor Genomic Profiling: When Should It Be Used in Clinical Practice?
Tumor genomic profiling helps identify actionable mutations to guide targeted therapies and clinical decisions. Understanding when to use it is key to maximizing its impact in precision oncology.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
FOLLOW US
LEARN ABOUT THE
ABOPM
CUSTOMER CARE
LEGAL
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.